• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中东欧国家特应性皮炎的隐性负担

The hidden burden of atopic dermatitis in central and Eastern European countries.

作者信息

Elezbawy Baher, Kaló Zoltán, Fasseeh Ahmad, Inotai András, Nemeth Bertalan, Ágh Tamás

机构信息

Department of Pharmaceutical Sciences, Doctoral School of Semmelweis University, Budapest, Hungary.

Department of Evidence Synthesis, Syreon Middle East, Alexandria, Egypt.

出版信息

Expert Rev Pharmacoecon Outcomes Res. 2025 Feb;25(2):257-264. doi: 10.1080/14737167.2024.2416249. Epub 2024 Oct 16.

DOI:10.1080/14737167.2024.2416249
PMID:39388211
Abstract

BACKGROUND

Atopic dermatitis (AD) imposes a hidden burden through its negative effects on quality of life and productivity. We aim to estimate this hidden burden in adults and adolescents in Central and Eastern European (CEE) countries.

METHODS

We created a burden of disease model to quantify AD's hidden burden. Humanistic burden was calculated by estimating the monetary value of quality-adjusted life years (QALYs) lost, using prevalence data from the Global Burden of Disease study and gross domestic product (GDP) per capita for each country. Indirect economic burden was estimated based on productivity loss from absenteeism and presenteeism, adjusted for labor force participation and unemployment rates. Total hidden burden was determined by combining productivity losses and QALYs lost.

RESULTS

QALY loss due to AD ranged from 1,832 to 58,596 annually in CEE countries, equating to 38 million to approximately 1 billion Euros per country. Productivity losses ranged from 3.6 to 148.9 million Euros annually. The total hidden burden of AD represents 0.11% to 0.43% of the GDP.

CONCLUSIONS

Our estimates reflect significant differences in population size, prevalence, and economic strength among CEE countries. Adjusting findings to country-specific GDP provided insights into AD's true hidden burden, offering valuable information for decision-making.

摘要

背景

特应性皮炎(AD)通过对生活质量和生产力产生负面影响而带来隐性负担。我们旨在评估中欧和东欧(CEE)国家成年人及青少年中的这一隐性负担。

方法

我们创建了一个疾病负担模型来量化AD的隐性负担。通过使用全球疾病负担研究中的患病率数据和各国人均国内生产总值(GDP)来估计损失的质量调整生命年(QALY)的货币价值,从而计算人文负担。间接经济负担是根据旷工和出勤主义导致的生产力损失来估计的,并根据劳动力参与率和失业率进行了调整。总隐性负担是通过将生产力损失和QALY损失相加来确定的。

结果

在中东欧国家,AD导致的QALY损失每年在1832至58596之间,相当于每个国家3800万至约10亿欧元。生产力损失每年在360万至1.489亿欧元之间。AD的总隐性负担占GDP的0.11%至0.43%。

结论

我们的估计反映了中东欧国家在人口规模、患病率和经济实力方面的显著差异。根据各国特定的GDP调整结果,深入了解了AD真正的隐性负担,为决策提供了有价值的信息。

相似文献

1
The hidden burden of atopic dermatitis in central and Eastern European countries.中东欧国家特应性皮炎的隐性负担
Expert Rev Pharmacoecon Outcomes Res. 2025 Feb;25(2):257-264. doi: 10.1080/14737167.2024.2416249. Epub 2024 Oct 16.
2
The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia.沙特阿拉伯成人和青少年特应性皮炎的人文和经济负担。
J Med Econ. 2022 Jan-Dec;25(1):1231-1239. doi: 10.1080/13696998.2022.2152234.
3
Economic burden of atopic dermatitis in Portugal: a cross-sectional study.葡萄牙特应性皮炎的经济负担:一项横断面研究。
Sci Rep. 2025 Mar 5;15(1):7717. doi: 10.1038/s41598-025-91896-y.
4
Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region.中东和非洲地区成人及青少年特应性皮炎的人文和经济负担
Dermatol Ther (Heidelb). 2023 Jan;13(1):131-146. doi: 10.1007/s13555-022-00857-0. Epub 2022 Nov 29.
5
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review.成人和青少年特应性皮炎的负担:一项系统文献综述。
Dermatol Ther (Heidelb). 2022 Dec;12(12):2653-2668. doi: 10.1007/s13555-022-00819-6. Epub 2022 Oct 5.
6
The Global Burden of Potential Productivity Loss from Uncorrected Presbyopia.全球未矫正老视导致的潜在生产力损失负担。
Ophthalmology. 2015 Aug;122(8):1706-10. doi: 10.1016/j.ophtha.2015.04.014.
7
Epidemiology and burden of chronic insomnia disorder in Europe: an analysis of the 2020 National Health and Wellness Survey.欧洲慢性失眠障碍的流行病学和负担:对 2020 年国家健康和健康调查的分析。
J Med Econ. 2024 Jan-Dec;27(1):1308-1319. doi: 10.1080/13696998.2024.2407631. Epub 2024 Oct 3.
8
Societal costs and health related quality of life in adult atopic dermatitis.成人特应性皮炎的社会成本及健康相关生活质量。
BMC Health Serv Res. 2023 Aug 14;23(1):859. doi: 10.1186/s12913-023-09840-7.
9
Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis.阿布昔替尼、特利鲁单抗和乌帕替尼治疗中重度特应性皮炎。
Health Technol Assess. 2024 Jan;28(4):1-113. doi: 10.3310/LEXB9006.
10
The Impact of Inflammatory Bowel Disease in Canada 2018: Indirect Costs of IBD Care.2018年加拿大炎症性肠病的影响:炎症性肠病护理的间接成本
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S34-S41. doi: 10.1093/jcag/gwy050. Epub 2018 Nov 2.